These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9063344)

  • 21. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort.
    Wolf PH; Madans JH; Finucane FF; Higgins M; Kleinman JC
    Am J Obstet Gynecol; 1991 Feb; 164(2):489-94. PubMed ID: 1992690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of hormone replacement therapy by postmenopausal women in the United States.
    Keating NL; Cleary PD; Rossi AS; Zaslavsky AM; Ayanian JZ
    Ann Intern Med; 1999 Apr; 130(7):545-53. PubMed ID: 10189323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women.
    Trémollieres FA; Pouilles JM; Ribot C
    Osteoporos Int; 2001; 12(5):385-90. PubMed ID: 11444087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone therapy use and prescription durations of menopausal women in Taiwan: a 5 years' National Cohort study.
    Kuo DJ; Lee YC; Huang WF
    Maturitas; 2007 Nov; 58(3):259-68. PubMed ID: 17920215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone replacement therapy in the aged. A state of the art review.
    Jacobs S; Hillard TC
    Drugs Aging; 1996 Mar; 8(3):193-213. PubMed ID: 8720745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemostatic variables and menopausal status: influence of hormone replacement therapy.
    Scarabin PY; Plu-Bureau G; Bara L; Bonithon-Kopp C; Guize L; Samama MM
    Thromb Haemost; 1993 Oct; 70(4):584-7. PubMed ID: 8115983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of hormone replacement therapy in Italian women aged 50-70 years.
    Manzoli L; Di Giovanni P; Del Duca L; De Aloysio D; Festi D; Capodicasa S; Monastra G; Romano F; Staniscia T
    Maturitas; 2004 Nov; 49(3):241-51. PubMed ID: 15488353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
    Neuner JM; McCarthy EP; Davis RB; Phillips RS
    J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mouse model to study the effects of hormone replacement therapy on normal mammary gland during menopause: enhanced proliferative response to estrogen in late postmenopausal mice.
    Raafat AM; Hofseth LJ; Li S; Bennett JM; Haslam SZ
    Endocrinology; 1999 Jun; 140(6):2570-80. PubMed ID: 10342844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
    Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
    BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.
    Lancaster T; Surman G; Lawrence M; Mant D; Vessey M; Thorogood M; Yudkin P; Daly E
    J Epidemiol Community Health; 1995 Aug; 49(4):389-94. PubMed ID: 7650462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coping with menopausal symptoms: An internet survey of Belgian postmenopausal women.
    Depypere H; Pintiaux A; Desreux J; Hendrickx M; Neven P; Marchowicz E; Albert V; Leclercq V; Van den Branden S; Rozenberg S
    Maturitas; 2016 Aug; 90():24-30. PubMed ID: 27282790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of different methods for including 'age at menopause' in analyses of the association between hormone replacement therapy use and breast cancer.
    Simpson JA; English DR; Macinnis RJ; Gertig DM; Hopper JL; Giles GG
    J Fam Plann Reprod Health Care; 2007 Jan; 33(1):11-6. PubMed ID: 17389089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy and the association with coronary heart disease and overall mortality: clinical application of the timing hypothesis.
    Hodis HN; Mack WJ
    J Steroid Biochem Mol Biol; 2014 Jul; 142():68-75. PubMed ID: 23851166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menopausal symptoms and knowledge towards daily life and hormone replacement therapy among menopausal women in Bangkok.
    Chaopotong P; Titapant V; Boriboonhirunsarn D
    J Med Assoc Thai; 2005 Dec; 88(12):1768-74. PubMed ID: 16518972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of the presence of hot flashes during menopause on the metabolism of nitric oxide. Effects of hormonal replacement treatment].
    Leal Hernández M; Abellán Alemán J; Carbonell Meseguer LF; Díaz Fernández J; García Sánchez FA; Martínez Selva JM
    Med Clin (Barc); 2000 Jan; 114(2):41-5. PubMed ID: 10702946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hormonal replacement therapy on skin biophysical properties of menopausal women.
    Guinot C; Malvy D; Ambroisine L; Latreille J; Mauger E; Guéhenneux S; Morizot F; Tschachler E
    Skin Res Technol; 2005 Aug; 11(3):201-4. PubMed ID: 15998332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.